NCT04434170View on ClinicalTrials.gov

Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

December 15, 2021

Conditions
Heart Failure
Interventions
DRUG

Sacubitril-Valsartan

outpatients who start treatment with sacubitril/valsartan according to guidelines will andergo cardiopulmonary exercise testing evaluation

Trial Locations (1)

20138

Centro Cardiologico Monzino, Milan

All Listed Sponsors
lead

Centro Cardiologico Monzino

OTHER

NCT04434170 - Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure | Biotech Hunter | Biotech Hunter